Literature DB >> 25924532

Investigation into the antioxidant and antidiabetic potential of Moringa stenopetala: identification of the active principles.

Solomon Habtemariam.   

Abstract

The fresh leaves of Moringa stenopetala (family, Moringaceae) are commonly eaten as cabbage while dried leaves are used as nutritional supplement and for treating a variety of disease conditions including diabetes. The present investigation into the therapeutic potential of the leaves and seeds of the plant revealed no inhibitory effect against α-glucosidase enzyme up to the concentration of 200 μg/mL but the leaves extract displayed potent DPPH (1,1-diphenyl-2- picrylhydrazyl) radical scavenging effect (IC50, 59.5 ± 4.1 μg/mL). An activity directed fractionation and isolation procedure resulted in the identification of the major antioxidant compound as rutin and minor active component, neochlorogenic acid. Both the crude extract (0.8-200 μg/mL) and rutin (0.8-200 μM) but not neochlorogenic acid displayed a concentration-dependent protection of human pancreatic β-cells (1.4E7 cells) from oxidant-induced cell death. The identification of these compounds along with their potential role in the nutritional and medicinal significance of the plant is discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25924532

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  8 in total

Review 1.  Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight.

Authors:  Solomon Habtemariam
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

2.  Could We Really Use Aloe vera Food Supplements to Treat Diabetes? Quality Control Issues.

Authors:  Solomon Habtemariam
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-06       Impact factor: 2.629

Review 3.  Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms.

Authors:  Taiwo Olayemi Elufioye; Tomayo Ireti Berida; Solomon Habtemariam
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-22       Impact factor: 2.629

Review 4.  Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.

Authors:  Solomon Habtemariam
Journal:  Int J Mol Sci       Date:  2018-02-03       Impact factor: 5.923

Review 5.  Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects.

Authors:  Solomon Habtemariam
Journal:  Molecules       Date:  2018-01-07       Impact factor: 4.411

Review 6.  The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease.

Authors:  Solomon Habtemariam
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

Review 7.  Dietary Anthocyanins and Insulin Resistance: When Food Becomes a Medicine.

Authors:  Tarun Belwal; Seyed Fazel Nabavi; Seyed Mohammad Nabavi; Solomon Habtemariam
Journal:  Nutrients       Date:  2017-10-12       Impact factor: 5.717

8.  Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62.

Authors:  Takanobu Takata; Akiko Sakasai-Sakai; Masayoshi Takeuchi
Journal:  Nutrients       Date:  2022-01-13       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.